Bio-Rad Laboratories | BIO - Stammkapital

Aktienkurs
287.84
Täglich Wechseln
6.42 2.28%
Monatlich
5.20%
Jährlich
18.77%
Q2 Prognose
281.68




Stammkapital Veränderung Datum
Abbott USD 1.74B 23.39B 2025-09
Agilent USD 282.7M 358K 2025-12
Becton, Dickinson and Co. USD 284.91M 1.72M 2025-12
Bio Techne USD 155.75M 154.18M 2025-09
Bio-Rad Laboratories USD 26.97M 90K 2025-09
Bruker USD 151.94M 225K 2025-12
Charles River Laboratories USD 49.22M 2K 2025-12
Danaher USD 707.7M 800K 2026-03
General Electric Aerospace USD 1.04B 5.43M 2026-03
Illumina USD 152.8M 900K 2025-12
IQVIA Holdings USD 169.6M 700K 2025-12
Laboratory Of America USD 82.2M 700K 2025-12
Merck USD 2.49B 15.79M 2025-09
Mettler Toledo International USD 20.43M 170.6K 2025-12
Myriad Genetics USD 93.5M 400K 2025-12
OraSure Technologies USD 70.39M 1.87M 2025-12
Pacific Biosciences Of California USD 301.96M 103K 2025-12
Quest Diagnostics USD 111M 1000K 2026-03
Repligen USD 56.32M 42K 2025-12
Revvity USD 113.38M 2.7M 2025-12
Roche Holding CHF 795.62M 699.54K 2025-12
Siemens EUR 780.74M 6.33M 2025-12
Standard Biotools USD 386.38M 2.77M 2025-12
Thermo Fisher Scientific USD 371.62M 4.09M 2026-03
Tosoh JPY 310.36M 5.45M 2025-12
Waters USD 98.08M 38.55M 2025-12